Promoter polymorphisms of the CD14 gene are associated with atopy in Pakistani adults. by Micheal, S. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/96231
 
 
 
Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
J Investig Allergol Clin Immunol 2011; Vol. 21(5): 394-397 © 2011 Esmon Publicidad
S Micheal, et al
ORIGINAL ARTICLE
Promoter Polymorphisms of the CD14 Gene 
Are Associated With Atopy in Pakistani 
Adults
S Micheal,1 K Minhas,1 M Ishaque,1 F Ahmed,2 A Ahmed1
1Department of Biosciences, COMSATS Institute of Information Technology, Islamabad, Pakistan
2The Allergy Centre, National Institute of Health, Islamabad, Pakistan
■ Abstract
Background: Several studies have shown that promoter polymorphisms of the CD14 gene are associated with atopic asthma. However, the 
results of association studies in different populations are confl icting. This study aimed to investigate the possible association between the 
CD14 polymorphisms A–1145G and C–159T and atopic phenotypes in Pakistani cohorts. 
Methods: Healthy controls (n=120) and atopic patients (n=220) were genotyped for the single-nucleotide polymorphisms C–159T 
(rs2569190) and A–1145G (rs2569191) using restriction fragment length polymorphism-polymerase chain reaction. 
Results: The genotype and allelic frequencies were in Hardy-Weinberg equilibrium. Overall, strong associations were observed between 
both C–159T (P=.02; χ2=7.16) and A–1145G (P=.01; χ2=7.88) and atopy. The G allele of A–1145G was signifi cantly associated with 
atopy (P<.009; χ2=6.72). When the data were stratifi ed, the associations observed were due to the individual phenotypes: atopic asthma 
was signifi cantly associated with A–1145G (P=.02; χ2=7.18), whereas the association between C–159T and atopy was attributed to 
patients with allergic rhinitis (P=.01; χ2=8.13). 
Conclusion: In Pakistani adults, the A–1145G polymorphism is associated with atopic asthma, whereas the C–159T polymorphism is 
signifi cantly associated with allergic rhinitis.  
Key words: Atopic asthma. Allergic rhinitis. CD14. Adults. Promoter polymorphisms. 
■ Resumen
Antecedentes: En varios estudios se ha demostrado que los polimorfi smos en el promotor del gen CD14 están asociados con el asma 
atópica. No obstante, los resultados de estudios de asociación en diferentes poblaciones resultan contradictorios. El objetivo de este 
estudio fue investigar la posible asociación entre los polimorfi smos A-1145G y C-159T del gen CD14 y fenotipos atópicos en cohortes de 
personas de origen paquistaní. 
Métodos: Se genotiparon los polimorfi smos de un solo nucleótido C-159T (rs2569190) y A-1145G (rs2569191) de controles sanos (n = 120) 
y pacientes atópicos (n = 220) mediante la reacción en cadena de la polimerasa-polimorfi smos de la longitud de fragmentos de restricción. 
Resultados: Las frecuencias genotípicas y alélicas se encontraban en equilibrio de Hardy-Weinberg. En general, se observaron asociaciones 
estrechas entre ambos polimorfi smos, C-159T (p=0,02; χ2=7,16) y A-1145G (p=0,01; χ2=7,88), y la atopia. El alelo G del polimorfi smo 
A-1145G mostró una asociación signifi cativa con la atopia (p<0,009; χ2=6,72). Al estratifi car los datos, las asociaciones observadas fueron 
debidas a los fenotipos individuales: el asma atópica mostró una asociación signifi cativa con el polimorfi smo A-1145G (p=0,02; χ2=7,18), 
mientras que la asociación entre el polimorfi smo C-159T y la atopia se atribuyó a pacientes con rinitis alérgica (p=0,01; χ2=8,13). 
Conclusión: En adultos paquistaníes, el polimorfi smo A-1145G está asociado con el asma atópica, mientras que el polimorfi smo C-159T 
está signifi cativamente asociado con la rinitis alérgica.  
Palabras clave: Asma atópica. Rinitis alérgica. CD14. Adultos. Polimorfi smos del promotor.
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Introduction
Atopic asthma is a complex phenotype caused by the interplay 
of genetic and environmental factors. Numerous loci and candidate 
genes have been reported to show linkage and association of 
atopic phenotypes with chromosome 5q31-33. Single-nucleotide 
polymorphisms (SNPs) within specifi c immunity genes including 
IL4, IL5, IL9, IL 4 alpha receptor, IL10, IL13, B2ADR, GR, and 
CD14 [1] are localized in this region.
CD14, a membrane glycoprotein (mCD14) expressed on 
the surface of monocytes, macrophages, granulocytes, and B 
lymphocytes, is an important molecule of the innate immune 
system, functioning as a carrier and receptor for microbial 
ligands. It is also present as soluble CD14 in serum [2]. Upon 
binding, CD14 signals enhance production of interleukin (IL) 12, 
which is in turn required for maturation of naïve T cells into 
type 1 helper T cells (TH1) cells, down-regulation of TH2 cells, 
and subsequent decreased immunoglobulin (Ig) E production 
[3]. Polymorphisms in the CD14 promoter region have been 
associated with atopic diseases and IgE levels. Five major 
genetic variants have been identifi ed in the promoter of the 
CD14 gene (C–159T, A–1619G, G–1359T, A–1145C, and 
A–809C) and are associated with atopic phenotypes in different 
ethnic groups [4]. However, reports are contradictory and 
further population studies are warranted. 
Material and Methods
We performed a genetic association study of the C–159T 
and A–1159G promoter polymorphisms. The population 
comprised a group of healthy controls (120 persons) and atopic 
patients (220 patients [110 with atopic asthma and 110 with 
allergic rhinitis]). The Ethics Committee of the Biosciences 
Department, COMSATS Institute of Information Technology, 
Islamabad, Pakistan approved the study and all participants 
gave their informed consent. A total of 120 controls and 220 
atopic patients (110 atopic asthma and 110 allergic rhinitis) 
were included in the study. Patients were recruited from the 
Table 1. Characteristic of the Study Population
  
  Controls Asthma Allergic
    Rhinitis 
No. of participants 120 100 100
   Gender, male/female 79/41 57/51 72/38
Mean (SD) age, y 30.3 (6.1) 31.52 (9.02) 32.07 (7.94)
   Mean log sIgE 
   levels, IU/mL 2.04 (0.05) 2.64 (0.07)a 2.28 (0.04)b,c
Positive skin prick 
test result 
   Mixed pollen – 53 47 
   Pollen + dust – 57 63 
aDifference between controls and asthma (P<.001)      
bDifference between controls and allergic rhinitis (P=.01) 
cDifference between asthma and allergic rhinitis (P<.001) 
Allergy Centre of the National Institute of Health in Islamabad, 
Pakistan. All atopic patients had positive skin prick test results 
to at least 1 of the common allergens being tested in the center 
(mixed dust, mixed pollen, thresher dust, paper mulberry 
pollen, mixed food) and an IgE level >100 IU/mL. Additionally, 
asthmatic patients had symptoms of cough or wheeze and 
chest tightness and a history of short attacks of breathlessness, 
whereas allergic rhinitis patients had symptoms of sneezing, 
runny nose, nasal obstruction, itchy nose, and rhinorrhea. All 
the healthy participants–no history of allergy as indicated by 
a negative skin prick test result to a series of aeroallergens and 
total serum IgE levels <100 IU/mL–served as age-matched 
and gender-matched controls. These individuals were recruited 
from a random population in Islamabad to ensure homogeneity. 
The characteristics of the study population are given in Table 1. 
Restriction fragment length polymorphism based on 
polymerase chain reaction was used to investigate C–159T 
(rs 2569190) and A–1145G (rs 2569190) [5]. Hardy-Weinberg 
equilibrium was calculated using the χ2 test. The statistical 
significance (χ2 test) of genotype and allele frequencies 
between patients and controls was determined using StatCalc 
v.6 (Epi Info, Atlanta, Georgia, USA). 
Table 2. Genotype and Allele Frequencies of C–159T and A–1145G in Controls and Atopic Patients
  Genotypes Controls Atopic P (χ2) P (χ2) OR (95% CI)
 
CC (C159T) 40 (33%) 46 (21%)            .01 (6.34) 1.89 (1.11-3.21)
CT (C159T) 49 (41%) 117 (53%) .02 (7.16) .02 (4.74) 0.61 (0.38-0.98)
TT  (C159T) 31 (26%) 57 (26%)  .98 (0.00) 1.00 (0.58-1.71)
AA (A1145G) 36 (30%) 38 (17%)                 .006 (7.39) 2.05 (1.18-3.58)
AG (A1145G) 56 (47%) 113 (51%)            .01 (7.88)   .4 (0.69) 0.83 (0.52-1.33)
GG (A1145G) 28 (23%) 69 (32%)                                             .11 (2.46)             0.67 (0.39-1.14)
Allele Controls All Atopic P (χ2) OR (95%CI)
C (C159T) 129 (54%) 209 (48%) <.11 (2.43) 1.28 (0.93-1.78)
T (C159T) 111 (46%) 231 (52%)                   
A (A1145G) 128 (53%) 189 (43%)                                                                                             
G (A1145G) 112 (47%) 251 (57%) <.009 (6.72)           1.52 (1.09-2.11)
Abbreviations: CI, confi dence interval; OR, odds ratio. 
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Results
The mean (SD) age of the controls (30.3 [6.1] years) 
and patients (31.3 [9.1] years) was not signifi cantly different 
(P=.21, t test). The genotype and allele frequencies of C159T 
and A1145G for controls and all atopic patients are presented 
in Table 2. Both polymorphisms were in Hardy-Weinberg 
equilibrium. Signifi cant associations were observed between 
both polymorphisms and atopy. This is in accordance with 
the study of Koppelman et al [6], who reported an association 
between CD14 and atopy.  
Interestingly, after data stratification, we found that 
C–159T was associated with allergic rhinitis but not asthma, 
whereas A–1145G was associated with atopic asthma but 
not allergic rhinitis. Table 3 shows the distribution of the 
genotype and allele frequencies of C–159T and A–1145G for 
controls and patients with atopic asthma and allergic rhinitis. 
No association was detected between asthma and C–159T 
(P=.20; χ2=3.21), although a signifi cant association was seen 
between the phenotype and A1145G (P=.02; χ2=7.18). The 
GG genotype was signifi cantly more frequent in the asthma 
patients (36%) than in the controls (23%). 
Discussion
Studies in populations from the Czech Republic [2], 
Korea [7], China [8], Australia [9], Germany [10], and the 
United States [11] show that C–159T does not play a role 
in the development of atopic asthma, whereas studies from 
populations in Brazil [12], Tunisia [13], Poland [14], and 
India [15] report the contrary. More recently, Zhang et al 
[16] performed a meta-analysis on all case-control CD14 
and asthma association studies and suggested that C–159T 
could be a protective factor for atopic asthma in Asian 
populations and children. Although our study population is 
Asian, it comprised adults only and is therefore consistent 
Table 3. Genotype and Allele Frequencies of C–159T and A–1145G in Controls, Patients With Atopic Asthma, and Patients With Allergic Rhinitis
Genotype Controls Asthma Pa Pa OR Allergic Pa Pa OR
      (95% CI) Rhinitis   (95% CI)
 
CC (C159T) 40 (33%) 25 (23%)   .07 (3.18) 1.70 (0.91-3.19) 21 (19%)  .01 (5.97) 2.12 (1.11-4.08)
CT (C159T) 49 (41%) 53 (48%) .20 (3.21) .26 (1.26) 0.74 (0.43-1.29) 64 (58%) .01 (8.13) .008 (6.91) 0.50 (0.28-0.87)
TT (C159T) 31 (26%) 32 (29%)  .58 (0.31) 0.85 (0.46-1.58) 25 (23%)  .58 (0.30) 1.18 (0.62-2.77)
AA (A1145G) 36 (30%) 19 (17%)  .02 (5.11) 2.05 (1.05-4.05) 19 (17%)  .02 (5.11) 2.05 (1.05-4.05)
AG (A1145G) 56 (47%) 51 (46%) .02 (7.18) .96 (0.00) 1.01 (0.58-1.76) 62 (56%) .07 (5.15) .14 (2.16) 0.68 (0.39-1.18)
GG (A1145G) 28 (23%) 40 (36%)  .03 (4.68) 0.53 (0.29-0.98) 29 (26%)  .59 (0.28) 0.85 (0.45-1.61)
Allele Controls Asthma P  OR (95% CI)  AR P OR (95% CI)
C (C159T) 129 (54%) 103 (47%) .13 (2.21) 1.32 (0.90-1.94) 106 (48%) .18 (1.79) 1.28 (0.80-1.88)
T (C159T) 111 (46%) 117 (53%)   114 (52%)
  
A (A1145G) 128 (53%) 89 (40%) .005 (7.64) 1.68 (1.14-2.48) 100 (45%) .09 (2.85) 1.37 (0.93-2.01)
G (A1145G) 112 (47%) 131 (60%)   120 (55%)  
Abbreviations: CI, confi dence interval; OR, odds ratio.
aAll P values by χ2 test.
with this fi nding. A comprehensive cross-sectional analysis by 
O’Donnell et al [17] showed increased prevalence of 159CC in 
atopic patients in childhood but not in adulthood. These data 
suggest that the effect of 159C on the atopic phenotype may 
be age-specifi c, exerting an effect during the middle period 
of childhood that is no longer apparent by early adulthood. 
Most studies investigated C–159T. However, A–1145G rather 
than C–159T could be involved in various atopic conditions, 
since tight linkage disequilibrium has been observed in both 
polymorphisms [10]. The association between A–1145G and 
atopic asthma is reported for the fi rst time in this study. The 
G allele was found to be signifi cantly higher in patients with 
atopic asthma (60%) than in controls (47%). 
  The association between C–159T and the allergic rhinitis 
group is consistent with the fi ndings of a study conducted 
on an adult Chinese population [18], in which a signifi cant 
association was observed. However, the frequency of the CT 
heterozygote was signifi cantly higher than controls (P=.01) 
in our study, as opposed to the Chinese study, in which the 
frequency of the TT homozygote was signifi cantly higher than 
in the control group (P<.05).     
We conclude that there is a signifi cant association between 
C–159T and allergic rhinitis and between A–1145G and 
atopic asthma in our population of adult Pakistanis. Our study 
demonstrates that different atopic phenotypes rather than 
populations may have a greater impact on CD14 association 
studies.   
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